Kitagawa Y - Search Results

1

Efficacy of tegafur-uracil in advanced urothelial cancer patients after the treatment failure of platinum-based chemotherapy.

Maolake A, Izumi K, Takahashi R, Itai S, Machioka K, Yaegashi H, Nohara T, Kitagawa Y, Kadono Y, Konaka H, Mizokami A, Namiki M. Maolake A, et al. Among authors: kitagawa y. Anticancer Res. 2015 Mar;35(3):1603-6. Anticancer Res. 2015. PMID: 25750316

2

Chemotherapy of metastatic testicular germ cell tumors: relationship of histologic response to size reduction and changes in tumor markers.

Koshida K, Kadono Y, Konaka H, Kitagawa Y, Imao T, Kobayashi T, Kunimi K, Uchibayashi T, Namiki M. Koshida K, et al. Among authors: kitagawa y. Int J Urol. 1998 Jan;5(1):74-9. doi: 10.1111/j.1442-2042.1998.tb00243.x. Int J Urol. 1998. PMID: 9535605 Free article.

3

Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas.

Kitagawa Y, Kunimi K, Ito H, Sato H, Uchibayashi T, Okada Y, Seiki M, Namiki M. Kitagawa Y, et al. J Urol. 1998 Oct;160(4):1540-5. J Urol. 1998. PMID: 9751409

4

Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas.

Kitagawa Y, Kunimi K, Uchibayashi T, Sato H, Namiki M. Kitagawa Y, et al. J Urol. 1999 Sep;162(3 Pt 1):905-9. doi: 10.1097/00005392-199909010-00088. J Urol. 1999. PMID: 10458406

5

Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT.

Kitagawa Y, Kyo S, Takakura M, Kanaya T, Koshida K, Namiki M, Inoue M. Kitagawa Y, et al. Clin Cancer Res. 2000 Jul;6(7):2868-75. Clin Cancer Res. 2000. PMID: 10914736

6

Antitumor effect of reduction of 150-kDa oxygen-regulated protein expression in human prostate cancer cells.

Miyagi T, Hori O, Egawa M, Kato H, Kitagawa Y, Konaka H, Ozawa K, Koshida K, Uchibayashi T, Ogawa S, Namiki M. Miyagi T, et al. Among authors: kitagawa y. Mol Urol. 2001 Summer;5(2):79-80. doi: 10.1089/109153601300177592. Mol Urol. 2001. PMID: 11690552 Review.

7

Antitumor effect of reduction of 150-kDa oxygen-regulated protein expression on human prostate cancer cells.

Miyagi T, Hori O, Koshida K, Egawa M, Kato H, Kitagawa Y, Ozawa K, Ogawa S, Namiki M. Miyagi T, et al. Among authors: kitagawa y. Int J Urol. 2002 Oct;9(10):577-85. doi: 10.1046/j.1442-2042.2002.00519.x. Int J Urol. 2002. PMID: 12445237 Free article.

8

Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system.

Miyagi T, Koshida K, Hori O, Konaka H, Katoh H, Kitagawa Y, Mizokami A, Egawa M, Ogawa S, Hamada H, Namiki M. Miyagi T, et al. Among authors: kitagawa y. J Gene Med. 2003 Jan;5(1):30-7. doi: 10.1002/jgm.317. J Gene Med. 2003. PMID: 12516049

9

Pathological effects of neoadjuvant hormonal therapy help predict progression of prostate cancer after radical prostatectomy.

Kitagawa Y, Koshida K, Mizokami A, Komatsu K, Nakashima S, Misaki T, Katsumi T, Namiki M. Kitagawa Y, et al. Int J Urol. 2003 Jul;10(7):377-82. doi: 10.1046/j.1442-2042.2003.00640.x. Int J Urol. 2003. PMID: 12823692 Free article. Clinical Trial.

10

Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.

Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, Yao Z, Keller ET. Fu Z, et al. Among authors: kitagawa y. Prostate. 2006 Feb 15;66(3):248-56. doi: 10.1002/pros.20319. Prostate. 2006. PMID: 16175585 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,778 results

Search Page

Filters